Innovative technologies for Cell & Gene Therapies
In June & July 2020 OUI and Ascenion joined forces to present a range of technologies for Cell & Gene therapies from the institutions that they represent.
The webinar featuring Oxford technologies, presented by OUI Licensing & Ventures Managers on 1st July 2020, is here:
At a glance
Details of individual technologies
-
- Gene therapy for chronic pain and epilepsy (Project 13911)
-
- Conditional Control of CRISPR technologies (Projects 13916 & 14361)
-
- Adjunct treatment for Gene Therapy (Project 14650)
-
- Gene therapy for retinitis pigmentosa (Projects 15619 and 15879 )
-
- Base editing proteins to repair mutations in the haemoglobin gene (Project 16008)
-
- OxVax, an emerging spinout
See also Project Profiles for projects 13911, 13916, 14361, 14650, 15619, 15879 and 16008.
© Oxford University Innovation